EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26.09.2025 / 18:40 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer Name: SCHOTT Pharma AG & Co. KGaA Street: Hattenbergstrasse 10 Postal code: 55122 City: Mainz
Germany Legal Entity Identifier (LEI): 529900TU48UE99NHEY88
2. Reason for notification X Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments Change of breakdown of voting rights Other reason:
3. Details of person subject to the notification obligation Legal entity: SMALLCAP World Fund, Inc.
City of registered office, country: Lutherville Timonium, United States of America (USA)
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached: 24 Sep 2025
6. Total positions % of voting rights attached to shares
(total of 7.a.) % of voting rights through instruments
(total of 7.b.1 + 7.b.2) Total of both in %
(7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 2.90 % 0.01 % 2.92 % 150614616 Previous notification 3.01 % 0.29 % 3.31 % /
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % Direct
(Sec. 33 WpHG) Indirect
(Sec. 34 WpHG) Direct
(Sec. 33 WpHG) Indirect
(Sec. 34 WpHG) DE000A3ENQ51 4373998 0 2.90 % 0 % Total 4373998 2.90 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % 0 0 % Total 0 0.00 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % Rights to recall lent shares of Common Stock Physical settlement 20301 0.01 % Total 20301 0.01 %
8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both % % %
10. Other explanatory remarks:
Date
25 Sep 2025
26.09.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at http://www.eqs-news.com
Language: English Company: SCHOTT Pharma AG & Co. KGaA Hattenbergstrasse 10 55122 Mainz Germany
End of News EQS News Service
2204664 26.09.2025 CET/CEST
Der heimische Aktienmarkt zeigte sich am Freitag höher. Der deutsche Aktienmarkt verzeichnete ebenfalls Gewinne. Die US-Börsen notieren zum Wochenschluss ungleich. Die wichtigsten Handelsplätze in Fernost schlossen am Freitag mit Verlusten.
